General Information of Disease (ID: DISOHFHE)

Disease Name Female sexual arousal dysfunction
Disease Class HA00-HA01: Sexual dysfunction
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISOHFHE: Female sexual arousal dysfunction
ICD Code
ICD-11
ICD-11: HA01.1
ICD-9
ICD-9: 302.7
Expand ICD-11
'HA0Z
Expand ICD-10
'F52; 'F52.1; 'F52.9
Expand ICD-9
302.7

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Flibanserin DM70DTN Approved Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
WC-3048 DMZ2Z62 Phase 3 NA [2]
OPC-14523 DMB1WF3 Phase 2 Small molecular drug [3]
PF-446687 DML38VU Phase 2 NA [4]
Pfizer 10 DM6ER9L Phase 1 NA [3]
Pfizer 4 DMME5P8 Phase 1 NA [3]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
PF-3274167 DMD42MN Discontinued in Phase 1 Small molecular drug [5]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BN-CB-045 DMBPTDC Preclinical NA [6]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 7 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AMSH DMO7EBX Investigative NA [3]
HPP-515 DMJYK63 Investigative NA [7]
ITI-003 DMA5BPG Investigative NA [7]
MT-II DMKT1DA Investigative Small molecular drug [3]
PF-271836 DMYSWAZ Investigative NA [8]
PL-6983 DMGG0F1 Investigative NA [7]
REC2615 DMJ0FCG Investigative Small molecular drug [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8182).
2 Transdermal testosterone for women: a new physiological approach for androgen therapy. Obstet Gynecol Surv. 2003 Jul;58(7):489-500.
3 Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66.
4 ClinicalTrials.gov (NCT00862888) Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction. U.S. National Institutes of Health.
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025596)
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023897)
7 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 369).